Arsenic inhibits stem cell differentiation by altering the interplay between the Wnt3a and Notch signaling pathways  by Bain, Lisa J. et al.
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Millions  of  people  are  exposed  to arsenic  through  their  drinking  water  and  food,  but the  mechanisms  by
which  it  impacts  embryonic  development  are  not  well  understood.  Arsenic  exposure  during  embryogen-
esis  is associated  with  neurodevelopmental  effects,  reduced  weight  gain,  and  altered  locomotor  activity,
and in  vitro  data  indicates  that arsenic  exposure  inhibits  stem  cell differentiation.  This  study  investigated
whether  arsenic  disrupted  the  Wnt3a  signaling  pathway,  critical  in  the  formation  of  myotubes  and  neu-
rons,  during  the  differentiation  in P19  mouse  embryonic  stem  cells.  Cells  were  exposed  to 0,  0.1,  or  0.5 M
arsenite,  with  or without  exogenous  Wnt3a,  for up  to  9 days  of  differentiation.  Arsenic  exposure  alone
inhibits  the  differentiation  of  stem  cells  into  neurons  and  skeletal  myotubes,  and  reduces  the  expression
of  both  -catenin  and  GSK3  mRNA  to ∼55% of  control  levels.  Co-culture  of the  arsenic-exposed  cells
with  exogenous  Wnt3a  rescues  the morphological  phenotype,  but does  not  alter  transcript,  protein,  or
phosphorylation  status  of  GSK3  or -catenin.  However,  arsenic  exposure  maintains  high  levels  of  Hes5
and  decreases  the expression  of  MASH1  by 2.2-fold,  which  are  anti-  and  pro-myogenic  and  neurogenicASH1
genes,  respectively,  in  the Notch  signaling  pathway.  While  rescue  with  exogenous  Wnt3a  reduced  Hes5
levels,  MASH1  levels  stay  repressed.  Thus,  while  Wnt3a  can  partially  rescue  the  inhibition  of differenti-
ation  from  arsenic,  it does  so  by  also  modulating  Notch  target  genes  rather  than  only  working  through
the  canonical  Wnt  signaling  pathway.  These  results  indicate  that  arsenic  alters  the  interplay  between
ays,  l
rs.  Pumultiple  signaling  pathw
© 2016  The  Autho
. Introduction
Arsenic is a contaminant in water systems around the world
37,58]. Although the U.S. EPA and the W.H.O. have set a limit of
0 ppb arsenic, millions of people drink water with higher arsenic
evels. In addition, arsenic has also been found at high levels in some
oods, such as rice [11,28,41]. Arsenic readily crosses the placental
arrier [10,24,72], and in utero exposure to arsenic has been linked
o an increased incidence of stillbirths, preterm births, and miscar-
iages starting at drinking water concentrations of ∼40 ppb arsenic
7,19,35,51,65].
Human epidemiological studies show that newborn weight and
eight gain in early childhood is reduced after arsenic exposure. For
xample, drinking water containing 40ppb arsenic has been asso-
iated with an average 57 g reduction in birth weight [19], while
aternal blood levels >5.3 ppb arsenic are associated with a 220 g
∗ Corresponding author at: Department of Biological Sciences, Clemson Univer-
ity, 132 Long Hall, Clemson, SC 23964, USA.
E-mail address: lbain@clemson.edu (L.J. Bain).
ttp://dx.doi.org/10.1016/j.toxrep.2016.03.011
214-7500/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).eading  to reduced  stem  cell  differentiation.
blished  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
reduction in birth weight [16]. The mechanisms behind the loss
of weight are not fully known. But, studies indicate that arsenic
can reduce myoblast differentiation into myotubes by decreasing
myogenin, the transcription factor important in muscle cell dif-
ferentiation [59,73]. Embryonic arsenite exposure can also alter
muscle ﬁber subtype [15].
Additionally, in utero and in vitro arsenic exposure is linked to
impacts on the developing nervous system. For example, arsenic
exposure is correlated with reductions in neuronal cell migration
and maturation at concentrations of 1–4 M in embryonic primary
rat neuroepithelial cells [55], at concentrations of 5–10 M arsenic
in PC12 and Neuro2a cells [14,68], and in postnatal day 11 pups
whose mothers were injected twice with 1 or 2 mg/kg arsenite
during pregnancy [12]. Arsenic exposure is also correlated with
reduced intellectual function in children at mean drinking water
levels ranging between 50 and 185 ppb [52,63,66,69,70]. These
studies collectively suggest that arsenic can disrupt muscle and
neuronal development. Indeed, in embryonic stem cells, 0.5 M
arsenite reduces the expression and localization of transcription
factors such as Myf5, MyoD, myogenin, NeuroD, and neurogenins,
all of which are needed to differentiate stem cells into skeletal
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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yotubes and sensory neurons [18]. Therefore, signaling pathways
pstream of neurons and skeletal myocytes are potential targets of
rsenic.
The canonical Wnt/-catenin signaling pathway is one such
athway that is important during embryogenesis. In the absence of
nt  ligand signaling, the co-transcription factor -catenin is ubiq-
itinated and degraded in the proteasome after phosphorylation by
asein kinase 1 (CK1) and glycogen synthase kinase 3  (GSK3).
hese proteins are held together by the scaffolding protein Axin
nd the adenomatous polyposis coli (APC) protein. When a Wnt  lig-
nd is present and bound to the cell surface proteins Frizzled (Fz)
nd low-density lipoprotein receptor related protein 6 (LRP6), Axin
s recruited to the plasma membrane, which inhibits -catenin’s
hosphorylation, and leads to its nuclear translocation. -catenin
inds with T-cell factor/lymphoid enhancer factor (TCF/LEF) tran-
cription factors to activate downstream target genes (reviewed in
ef. [31]).
Wnt  signaling molecules, such as Wnt1, Wnt3, Wnt3a, and Wnt5
23,26,33], play a critical role in the development of muscle and
eurons. Wnt3a is speciﬁcally important for both paraxial meso-
erm and neural tube development [23,48,60,74]. For example,
he Wnt/-catenin pathway induces early mesodermal markers
uch as Brachyury and FoxA2 [62] and activates Myf5 in somites,
hich is one of the early transcription factors needed for skele-
al muscle development [1,5]. In human embryonic stem cells,
nt3a promotes the commitment to myogenic cells [22]. Wnt3a
s also needed for neurogenesis, speciﬁcally in the growth of the
eural tube [40] and in neural crest cell speciﬁcation [13], which
re needed for sensory neuron formation. In vitro, the addition of
nt3a-conditioned medium to P19 mouse embryonic stem cells
ncreased the expression of III-tubulin, a speciﬁc marker of neu-
onal cells [36].
Our previous study demonstrated that arsenic exposure inhib-
ted the ability of P19 cells to differentiate into skeletal myotubes
nd sensory neurons. We  hypothesized that a potential mecha-
ism for the reduced differentiation was via the Wnt/-catenin
athway, since -catenin protein expression was decreased [18].
ndeed others have shown that arsenic can alter proteins within
he Wnt  signaling pathway. For example, after an in utero exposure
o arsenic, the lungs of embryonic day 18 rats had reductions in
oth -catenin and GSK3 transcripts [49], while arsenic exposure
o SH-SY5Y neuroblastoma cells decreases GSK3 activity [71].
The current study shows that exogenous Wnt3a can effectively
escue the arsenic-mediated inhibition of P19 stem cell differen-
iation into skeletal myotubes, but not sensory neurons. Although
rsenic exposure reduces the expression of -catenin and GSK3
ranscripts, these are not rescued by exogenous Wnt3a. Arsenic
xposure reduces levels of the pro-neurogenic transcript Mash1
hile maintaining high levels of Hes5. However, the addition of
nt3a reduces Hes5 levels, and helps to rescue the inhibition of
ellular differentiation caused by arsenic. This study underscores
he complexity of arsenic-induced changes in cellular differenti-
tion and highlights the cross-talk between the Wnt  and Notch
ignaling pathways.
. Materials and methods
.1. P19 cell culture and differentiation
P19 mouse embryonic stem cells (ATCC, Manasass, VA) were cul-
ured in -MEM containing 7.5% bovine calf serum (Hyclone, Logan,
T), 2.5% fetal bovine serum (Mediatech, Manassas, VA), and 1% l-
lutamine (Hyclone) in an incubator at 37 ◦C with 5% CO2. Cells
ere subcultured every 2 days. For differentiation experiments, 1%
MSO was added to the medium, which is a typical compound usedorts 3 (2016) 405–413
with these cells to form skeletal muscle cells [57]. Cells were aggre-
gated for 2 days in hanging drops (500 cells/20 L drop) [67] with
0, 0.1, or 0.5 M arsenic as sodium arsenite (Sigma, St. Louis, MO).
We have previously shown that these arsenic concentrations do not
affect cell viability, but do reduce their ability to differentiate into
sensory neurons and skeletal myotubes [18].
After 2 days, each drop was  transferred to an individual well in a
96-well ultralow attachment plate for an additional 3 days (day 5)
to form a mature embryoid body. To further differentiate the cells,
they were transferred to 48 well plates coated with 0.1% gelatin for
up to 4 additional days (day 9). The medium was  renewed every
2 days until the cells were harvested, and the arsenic exposures
continued throughout the differentiation process. When day 5 and
9 cells were harvested, all the wells from each 96-well plate were
combined into one replicate (n = 3 plates per arsenic concentra-
tion). Cells were harvested in TRI Reagent (Sigma, St. Louis, MO)
and stored at −80 ◦C.
2.2. Exosome isolation
Cell culture medium was also collected from day 5 embry-
oid bodies to collect exosomes. Brieﬂy, medium was passed
through a 0.2 m ﬁlter and incubated with ExoQuick-TC isolation
reagent overnight at 4 ◦C (Systems Biosciences, Mountain View,
CA). Exosomes were isolated by centrifugation per manufactuer’s
instructions and lysed in RIPA buffer with protease and phosphtase
inhibitors. Protein concentrations were quantiﬁed using Bio-Rad’s
DC protein assay kit.
2.3. L-cell and wnt3a conditioned medium collection
L-Wnt-3A cells and L-cells (ATCC) were cultured in DMEM
containing 10% FBS and 1% l-glutamine. To produce conditioned
medium, cells were split 1:10 and cultured for 4 days. The medium
was removed and another 10 mL  fresh culture medium added for
an additional 3 days. The two  sets of conditioned medium were
combined, ﬁltered, and stored at 4 ◦C. Once enough medium was
obtained, it was  ﬁltered through Amicon Pro 30 kD Ultra ﬁltration
system (EMD Millipore, Billerica, MA)  to concentrate the proteins.
The conditioned concentrate was  resuspended to its original vol-
ume  in P19 cell differentiation medium and stored at −20 ◦C until
use.
2.4. Exposure of P19 cells to L- or Wnt3a-conditioned medium
P19 cells were aggregated into embryoid bodies and differen-
tiated into sensory neurons and skeletal myotubes as described
above in either L-cell or Wnt3a conditioned medium. Concomi-
tantly, they were exposed to sodium arsenite at 0, 0.1, or 0.5 M.
Embryoid bodies or differentiated cells were collected after 5 or
9 days in either TRI Reagent (Sigma) for qPCR experiments or in
RIPA buffer (Pierce Biotechnology, Rockford, IL) containing both
phosphatase and protease inhibitors (Pierce) for immunoblotting
and immunoprecipitation experiments.
2.5. qPCR
Total RNA was extracted using TRI Reagent, quantitated by
spectrophotometry, and cDNA (2 g) was  prepared by reverse
transcription. The expression of Wnt3a, Wnt8a, LRP5, glycogen
synthase kinase 3 (GSK3),  CK1, -catenin, APC, Axin, PTEN,
lymphoid enhancer-binding factor 1 (LEF1), Dkk1, Dkk4, Myogenin,
Neurogenin1, Hes1, and Hes5 was  examined by qPCR. Brieﬂy, 40 ng
cDNA were incubated with SYBR Green (Qiagen, Alameda, CA) and
gene speciﬁc primers (Table S1) to examine levels of transcripts. All
samples were run in triplicate. A standard curve (10−3ng–10−7ng)
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Fig. 1. Wnt3a co-exposure rescues the arsenic-induced inhibition of stem cell differentiation.
P19 cells were aggregated to form embryoid bodies that were then allowed to differentiate for 7–9 days in the presence of 0, 0.1, or 0.5 M arsenic. Cells were grown in either
L-cell  conditioned medium (A) or in Wnt3a-conditioned medium (B). Elongated and multinucleated myotubes are indicated by arrows and neurons with dendritic processes
are  indicated by arrowheads.
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Fig. 2. Arsenic reduces -catenin transcripts in day 5 embryoid bodies.
P19 cells were cultured in L-cell or Wnt3a-conditioned medium during the 5 days of embryoid body formation while being co-exposed to 0, 0.1, or 0.5 M arsenite. The levels
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.6. Immunoblotting
Cells were lysed in RIPA buffer containing protease and phos-
hatase inhibitors. The cell suspension was centrifuged at 15,000g
or 15 min  to remove debris, and protein levels in the supernatant
uantiﬁed with BioRad’s DC protein assay. Proteins (5–10 g) were
lectrophoresed and transferred per standard methods, prior to
locking in 5% milk/TBST. All primary antibodies were diluted
:1000 in TBST and were incubated overnight at 4 ◦C. The antibodies
ncluded anti--catenin (Cell Signaling no. 9562), anti-GSK3 (Cell
ignaling no. 9315), anti-Wnt3a (R&D Systems no. MAB1324-050),
nd anti-Wnt8a (R&D Systems no. AF2248). Anti-GAPDH antibody
Genetex no. GT-239) was used as a loading control. The appro-
riate secondary HRP-conjugated antibody (1:2000 dilution, Santa
ruz) was incubated with the blot and proteins were detected using
uminol reagent (Santa Cruz). Band intensity was  determined by
ensitometry.
.7. Immunoprecipitation for phosphorylated ˇ-catenin and
SK3ˇ
Cell lysates (50 g) were incubated overnight at 4 ◦C with either
nti--catenin or GSK3 at a 1:100 dilution. Dynabeads Protein G
Life Technologies) were added to the suspension for 2 h at 4 ◦C
nd the speciﬁc protein immunoprecipitated. After denaturing, the
roteins were electrophoresed, transferred, and blocked. Primary
ntibodies (anti-phospho-GSK3 (Ser9), Cell Signaling no. 9323,
nti-phospho--catenin (Thr41/Ser45), Cell Signaling no. 9565, and
nti-phospho--catenin (Ser33/37/Thr41, Cell Signaling no. 9561))
ere diluted 1:1000 in TBST and incubated with the blot overnightwas run in triplicate (n = 3), results were normalized to GAPDH, and are expressed
d by ANOVA followed by Tukey’s post hoc test (p < 0.05) to determine statistical
edium (#).
at 4 ◦C. The anti-rabbit HRP secondary antibody (1:2000) was incu-
bated with the blot and proteins were detected using Luminol
reagent (Santa Cruz). Band intensity was determined by densito-
metry, with MHC  used as the loading control.
2.8. Statistics
For transcript levels, the replicates (n = 3) of each exposure
group were averaged together and statistical signiﬁcance deter-
mined by ANOVA followed by Tukey’s (p < 0.05). Protein levels were
assessed by immunoblotting followed by densitometry. These val-
ues were converted into a relative intensity for each group (n = 2–3;
replicated at least twice), and statistical signiﬁcance determined by
ANOVA followed by Tukey’s (p < 0.05).
3. Results
3.1. Arsenic exposure during embryoid body formation reduces
ˇ-catenin transcripts
Previous research indicated that arsenic exposure reduced dif-
ferentiation of stem cells into skeletal muscles and sensory neurons
by reducing the expression of key transcription factors, such as
myogenin and neurogenin [18]. Since -catenin expression was
also reduced, we hypothesized that arsenic targeted proteins
involved in the canonical Wnt  signaling pathway during early
cell fate determination. Thus, transcript levels of several genes
important in this pathway were examined. At day 5 of embryoid
body formation, -catenin and LEF expression were both signiﬁ-
cantly reduced (Table 1), while Lrp5 expression was  signiﬁcantly
increased. Although expression of GSK3 was  lower in the arsenic-
exposed cells, this was  not statistically signiﬁcant (p = 0.1).
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Fig. 3. Wnt3a co-exposure rescues the levels of Myogenin and Neurogenin1, but does not rescue the reduction in -catenin and GSK3 transcripts in day 9 differentiated
cells  treated with arsenic.
P19 cells were cultured in L-cell or Wnt3a-conditioned medium during the 9 days of differentiation while being co-exposed to 0 or 0.5 M arsenite. The levels of Wnt3a,
LEF,  Myogenin, Neurogenin1, -catenin, and GSK3 transcripts were quantiﬁed by qPCR
are  expressed as the average normalized number of molecules. Statistical differences we
statistical differences between arsenic concentrations (*) and between L- and Wnt3a-con
Table 1
Relative transcript levels of proteins involved in the Wnt  signaling pathway after
0.5 M arsenic exposure. Embryoid bodies were exposed to 0 or 0.5 M arsenic
for  5 days, and fold-changes in transcript levels between the exposed EBs and the
control EBs were determined by qPCR.
Transcript name Day 5 fold changea
LRP5 1.42 ± 0.10*
APC 1.15 ± 0.18
Axin 1.08 ± 0.09
GSK3 0.80 ± 0.13
CK1 1.04 ± 0.14
-catenin 0.61 ± 0.09*
LEF 0.79 ± 0.03*
PTEN 1.18 ± 0.13
DKK1 0.90 ± 0.18
DKK4 1.30 ± 0.38
a Fold change is expressed as transcript number in the arsenic-exposed embryoid
bodies divided by transcript number in the control embryoid bodies (n = 3; aver-
age ± S.D.).
* p < 0.05.. Each sample was run in triplicate (n = 3), results were normalized to GAPDH, and
re determined by ANOVA followed by Tukey’s post hoc test (p < 0.05) to determine
ditioned medium (#).
3.2. Exogenous Wnt3a rescues the arsenic-induced inhibition of
differentiation, but does not alter ˇ-catenin levels
Exogenous Wnt3a was  added to the cells to determine whether
this protein could rescue the arsenic-mediated reduction in cell
differentiation. Conditioned, ﬁltered medium from L- cells and
L/Wnt3a cells (Fig. S1) were used to co-expose cells treated with
0, 0.1, or 0.5 M arsenic for either 5 days (embryoid body for-
mation) or 9 days (differentiated skeletal myotubes and neurons).
Arsenic reduced the formation of neurons and skeletal myocytes in
a dose-responsive manner after 7–9 days of exposure in L-cell con-
taining medium (Fig. 1A). However, when cells were treated with
Wnt3a conditioned medium, both the control and arsenic exposed
cells had many more myotubes (Fig. 1B), indicating that Wnt3a
co-exposure can rescue the effects of arsenic exposure on cellular
differentiation.
After 5 days of embryoid body formation, the transcript lev-
els of a Wnt3a target gene, LEF, was  signiﬁcantly increased in the
Wnt3a-conditioned medium groups over the L-cell groups (Fig. 2).
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Fig. 4. Arsenic does not alter protein levels of -catenin and GSK3 in day 9 differentiated cells.
P19 cells were cultured in L-cell or Wnt3a-conditioned medium during the 9 days of differentiation while being co-exposed to 0, 0.1, or 0.5 M arsenite. The levels of -catenin
a hown.
t iﬁc an
M
T
e
c
e
e
o
m
m
d
i
w
w
f
N
r
g
w
(
i
r
W

i
c
a
d
l
3
s
cnd  GSK3 were determined by immunoblotting, with representative blots (n = 3) s
ion  was conducted using antibodies that recognize the total protein. Phospho-spec
yosin  heavy chain (MHC) provides a loading control.
hese ﬁndings indicate that Wnt3a was available and active in the
xposures. Interestingly, Wnt8a levels were reduced in the Wnt3-
onditioned medium groups by 1.6- to 2-fold, but arsenic had no
ffect on its expression (data not shown). Similar to Table 1, arsenic
xposure signiﬁcantly reduced -catenin mRNA expression to 61%
f control levels (Fig. 2), but this was not rescued with Wnt3a treat-
ent.
To understand the mechanisms responsible for the Wnt3a-
ediated rescue, mRNA expression was examined in the day 9
ifferentiated cells seen in Fig. 1. Wnt3a mRNA levels were still
ncreased after exposure to Wnt3a-conditioned medium for 9 days,
hile LEF levels were not changed anymore (Fig. 3), unlike what
as seen after 5 days of exposure. To conﬁrm the rescue of dif-
erentiation with Wnt3a co-exposure, the levels of Myogenin and
eurogenin 1 were assessed. Myogenin levels were signiﬁcantly
educed to 56% of the controls in the 0.5 M arsenic exposed cells
rown in L-cell conditioned medium, which was partially rescued
ith the Wnt3a exposure, going to back to 83% of the controls
Fig. 3). However, while Neurogenin1 was also signiﬁcantly reduced
n the arsenic-exposed L-cell medium, Wnt3a co-exposure further
educed Neurogenin1 levels, down to 33% of the controls (Fig. 3).
hile arsenic exposure signiﬁcantly reduced the expression of both
-catenin and GSK3 mRNA to ∼55% of control levels, this was
rrespective of whether the cells were cultured in L-cell or Wnt3a-
onditioned medium (Fig. 3). The transcript data indicates that
lthough Wnt3a rescues the muscle phenotype of arsenic-induced
ifferentiation inhibition, it does not do so by altering transcript
evels of GSK3 or -catenin.
.3. Arsenic does not alter protein levels nor the phosphorylation
tatus of GSK3  ˇ or ˇ-catenin
Next, protein levels and phosphorylation status of GSK3 and -
atenin were examined. In the absence of Wnt  signaling, -catenin To examine the phosphorylation state of -catenin and GSK3, immunoprecipata-
tibodies were used for immunoblotting, with representative images (n = 2) shown.
is ﬁrst phosphorylated at S45 by CK1 and then phosphory-
lated at S33/S37 by GSK3, which results in its degradation [45].
There were no changes in total -catenin protein in day 9 cells
exposed to arsenic, nor were there difference between the L-
cell and Wnt3a-conditioned medium treatments (Fig. 4). Similarly,
phosphorylation of -catenin at S33/S37, T41/S45, total GSK3, or
S9-phospho- GSK3 levels were not signiﬁcantly altered by arsenic
(Fig. 4). These results indicate that arsenic does not impact pro-
tein expression of GSK3 or -catenin [32], nor does it alter the
phosphorylation status of either GSK3 or -catenin.
3.4. Neither Wnt3a nor Wnt8a levels are changed by arsenic
There are several other mechanistic possibilities for how exoge-
nous Wnt3a could rescue the phenotype of reduced differentiation
due to arsenic exposure, such as altering the noncanonical Wnt  sig-
naling pathway. The levels of Wnt3a in day 9 cells and exosomes
were not changed due to arsenic exposure (Fig. S2). While there is
robust expression of Wnt8a in exosomes (Fig. S2), its level is not
changed by arsenic. There is little expression of Wnt3a and Wnt8a
in exosome-depleted medium (data not shown). While Wnt3a is
expressed in cells, its levels are unchanged by arsenic (Fig. S2).
Wnt8a levels in the cells were not detectable (data not shown).
3.5. Arsenic reduces Mash1 levels, which cannot be rescued by
exogenous Wnt3a
Another mechanistic possibility for the Wnt3a rescue is to alter
cross-talk between multiple pathways. For example, the Wnt  and
Notch pathways are required to work together to regulate many
aspects of cell fate determination during development [8,42]. We
examined the levels of two  target genes in the Notch signaling path-
way, Hes1 and Hes5 [25], in day 9 differentiated cells. There were
no differences in Hes1 transcript levels in arsenic- and/or Wnt3a-
L.J. Bain et al. / Toxicology Rep
Fig. 5. Changes in Hes5 mRNA expression due to arsenic exposure can be rescued
by exogenous Wnt3a.
mRNA was  extracted from P19 cells co-exposed to Wnt3a conditioned medium and
0.5  M arsenic for 9 days. The levels of Hes1, Hes5, and MASH1 were assessed by
qPCR. Each sample was  run in triplicate (n = 3), results were normalized to GAPDH,
and  are expressed as the average normalized number of molecules. Statistical dif-
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cerences were determined by ANOVA followed by Tukey’s post hoc test (p < 0.05) to
etermine statistical differences between arsenic concentrations (*) and between
-  and Wnt3a-conditioned medium (#).
xposed cells (Fig. 5). Typically, decreases in the expression of Hes5,
 Notch signaling pathway target gene, lead to increases in MASH1
nd therefore lead to cellular differentiation [43]. We  found that
rsenic exposure to day 9 differentiated cells does just the opposite,
y keeping Hes5 levels high and reducing MASH1 transcript lev-
ls by 2.2-fold (Fig. 5). When arsenic-exposed cells are cultured in
nt3a-containing medium, Hes5 levels are reduced in order to res-
ue the phenotype, but MASH1 levels still remain repressed (Fig. 5).
hus, while Wnt3a can partially rescue the inhibition of differen-
iation due to arsenic exposure, it appears to do so by modulating
otch target genes, such as Hes5, rather than working through the
anonical Wnt  signaling pathway.orts 3 (2016) 405–413 411
4. Discussion
This study shows that arsenic exposure inhibits stem cell
differentiation into skeletal myotubes and sensory neurons, in
part, by reducing the expression of -catenin, GSK3,  Hes5, and
MASH1/Ascl1 transcripts. The cellular phenotype can effectively be
rescued by exogenous Wnt3a, but interestingly, while Hes5 expres-
sion can be inhibited and myogenin expression can be increased
with Wnt3a co-exposure, Wnt3a does not change the expression
of MASH1, GSK3, or -catenin. The results highlight how chemi-
cals, such as arsenic, can impair the interplay between the Wnt  and
Notch pathways in cellular differentiation.
We have previously shown that low levels of arsenic inhibit
stem cell differentiation into sensory neurons and skeletal mus-
cles, and hypothesized that these morphological changes were due
to impaired Wnt  signaling. Others have also shown that arsenic
can impair activity or reduce transcripts of -catenin and GSK3
[44,49,71], which are key proteins in the Wnt3a signaling path-
way. In the present study, we  conﬁrm that -catenin transcripts are
reduced due to arsenic exposure at both the early phases of embry-
oid body formation [18,38] and show that this repression continues
throughout the differentiation period, up to day 9 in which sensory
neurons and skeletal myotubes have formed.
Both -catenin and GSK3 play an important role in the canon-
ical Wnt3a signaling pathway. Indeed, Wnt3a can increase the
skeletal muscle-speciﬁc transcript MyoD by targeting its distal
enhancer [46], and Wnt3a is important is sensory neuron forma-
tion during development [48]. Studies have shown that in myogenic
and neurogenic precursor cells, exogenous Wnt3a enhances differ-
entiation [2,6,21]. During the co-exposure of P19 cells, exogenous
Wnt3a was  able to rescue the arsenic-induced reduction of differ-
entiation. However, neither -catenin nor GSK3 transcript levels
were not increased with the Wnt3a co-exposure at either day 5 or
day 9.
Recent evidence indicates that exogenous Wnt3a increases the
differentiation of stem cells by the using both canonical and non-
canonical signaling pathways [56]. For example, when Wnt3a
was exposed to iPS-induced neural progenitor cells, neurogenesis
increased, but these effects could not be mimicked with stabi-
lized -catenin [21]. Similarly, neuronal differentiation of either
embryonic stem cells or induced pluripotent stem cells can be
blocked if Wnt3a is inhibited or silenced, but not when -catenin
signaling is inhibited [2]. Thus, -catenin-independent Wnt  sig-
naling may  be driving stem cell differentiation. Indeed, it appears
that there is a switch between canonical and non-canonical Wnt
signaling part way  through neuronal differentiation. The earlier
time points appear to work through the Wnt3a/-catenin path-
way, while in later stages of neuronal differentiation, Wnt3a/JNK
signaling activates the AP-1 family of proteins [2]. This may  explain
why transcript levels of -catenin are altered without a change in
protein levels in day 9 differentiated cells. Other investigators have
shown that arsenic can activate the ERK and JNK pathways in sev-
eral different cells types [20,34]. The Wnt/PCP and Wnt/calcium
signaling pathways do not appear to play a major role in neuronal
differentiation, at least in vitro [2].
There is also cross-talk between the canonical Wnt3a signaling
pathways and others. For example, membrane-bound Notch can
bind to unphosphorylated -catenin in stem cells and prevent it
from accumulating in the nucleus, a process that does not require
GSK3 activity [29]. Previous studies have indicates that arsenic
exposure does not alter either total or S9-phospho-GSK3 levels in
day 5 embryoid bodies [32]. Our current results indicate that in day
9 differentiated cells, arsenic does not alter either total or phospho-
GSK3, nor are these levels altered by the addition of Wnt3a. While
we have previously shown that -catenin nuclear translocation is
signiﬁcantly reduced in arsenic-exposed day 2 and day 5 embryoid
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odies [18], this may  be in part due to a switch from canonical
o non-canonical pathways during the differentiation process, and
ay  also be due to another signaling pathway.
The Notch signaling pathway plays an opposing role to Wnt3a
n stem cell differentiation to neurons and myocytes [9,75]. To
nhance differentiation, Wnt3a target proteins are kept at high lev-
ls, while Notch target transcription factors, such as Hes1 and Hes5
re reduced [25,43], likely in part because  − catenin can bind to
he Hes1 promoter [30]. Hes proteins work to repress neurogenesis
y actively binding to N-boxes on the promoters of neurogenic tran-
cription factors, such as the neurogenins and Ascl1/MASH1, and
revent their transcription. They can also passively inhibit myoge-
esis by forming heterodimers with MASH1 and prevent its binding
o E-boxes on the promoters of myogenic transcription factors, such
s MyoD (reviewed in Ref. [27]).
In the central nervous system, Hes1 is expressed in the earliest
euroepithelial cell types, while Hes5 expression occurs in more
ifferentiated cell types [27]. Indeed, in human and mouse mus-
le stem cells, Hes5 rather than Hes1 drives the expression of the
uscle-speciﬁc transcription factors MyoD and myogenin [50,54].
nce Hes5 levels drop, the levels of the pro-myogenic and pro-
eurogenic protein MASH1 increase to drive cellular differentiation
3,39,43,53,76]. We  ﬁnd that undifferentiated day 5 embryoid bod-
es express 3.8- to 4-fold higher Hes1 and Hes5 levels (Fig. S3) than
o day 9 differentiated cells. Due to the high Hes levels in day 5
mbryoid bodies, MASH1 levels are 2.5-fold lower (Fig. S3) than in
ay 9 differentiated cells.
By day 9, Hes1 and Hes5 transcripts are both reduced by ∼4-fold,
hich, in control cells, is accompanied by an increase is MASH1
evels, thus allowing neurogenesis and myogenesis to occur. Inter-
stingly, arsenic exposure does not alter the levels of Hes1 or Hes5,
ut it does decrease MASH1 levels by 2-fold. During the early stages
f differentiation, Hes5 necessary to start production of MASH1
47], but then later, MASH1 turns off Hes5 production by binding to
n E-box region within the Hes5 promoter [64]. When exogenous
nt3a is co-cultured with these cells up to day 9, Hes1 levels do
ot change, whether the cells are exposed to arsenic of not. With
he co-exposure to Wnt3a, Hes5 levels are reduced by 3-fold, which
mplies that Wnt3a can rescue differentiation. Indeed, when Wnt3a
as exposed to iPS-induced neural progenitor cells, Hes5 lev-
ls were dramatically reduced, MASH1 expression was increased
43], and neurogenesis increased [21]. Interestingly though, the
o-exposure of Wnt3a and arsenic keep the levels of MASH1 signiﬁ-
antly reduced. Taken together, our data suggests that the feedback
oop between Hes5 and MASH1 is somehow disrupted by arsenic.
How arsenic disrupts the feedback loops between the Hes
roteins and MASH1 is not known. One possibility is through epige-
etic regulation. Hes1 expression is induced after Notch activation,
nd then oscillates due to a negative feedback loop, as the Hes1
rotein binds to N-box sequences in its promoter and represses its
xpression. Furthermore, both Hes1 mRNA and protein are unstable
17]. We only examined Hes1 levels on a day-to-day basis, and so
hether arsenic is disrupting the appropriate oscillation patterns
s unknown. However, microRNA-9 (miR-9) has been proposed to
egulate the oscillatory expression of Hes1 since the oscillation pat-
ern is dampened in miR-9 knockouts [4,61]. We  have shown that
rsenic exposure in day 5 and day 9 P19 cells decreases the levels of
iR-9 (data not shown), which might indicate that Hes1 is not oscil-
ating appropriately. Thus, while Wnt3a can partially rescue the
nhibition of differentiation due to arsenic exposure, it appears to do
o by modulating Notch target genes rather than working through
he canonical Wnt  signaling pathway. Overall, this study indicates potential mechanism for the arsenic-induced reduction in stem
ell differentiation, due to the inhibition of MASH1. These results
urther support that arsenic can impact the feedback loops between
he Wnt  and Notch pathways during cellular differentiation.
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